McIntyre Roger S, Konarski Jakub Z, Wilkins Kathryn, Soczynska Joanna K, Kennedy Sidney H
Department of Psychiatry and Pharmacology, University of Toronto, Ontario.
Can J Psychiatry. 2006 Apr;51(5):274-80. doi: 10.1177/070674370605100502.
We aimed to ascertain the prevalence of obesity in individuals with a mood disorder (MD) (that is, bipolar disorder or major depressive disorder), compared with the general population. We further aimed to examine the likelihood of an association between obesity and MD, while controlling for the influence of sociodemographic variables.
The analysis was based on data from Statistics Canada's Canadian Community Health Survey: Mental Health and Well-Being (CCHS 1.2), conducted in 2002. The sample (n = 36 984; > or = aged 15 years) was drawn from the Canadian household-dwelling population. The CCHS used diagnostic criteria outlined in the DSM-IV to screen respondents.
Individuals with a lifetime history of MD were more likely to be obese (body mass index [BMI] > 30) than were individuals without lifetime MD (19%, compared with 15%, respectively; P < 0.001). In sex-specific multivariate analysis, lifetime MD was associated with elevated odds of obesity in female respondents (95%CI, 1.03 to 1.46, odds ratio 1.22), but not in male respondents. Antipsychotic pharmacotherapy was also associated with obesity.
This is the first Canadian epidemiologic investigation to specifically evaluate anthropometric indices and associated factors in people with MDs. The results herein supplement substantial clinical evidence documenting the association between MDs and stress-sensitive somatic disorders (for example, obesity). These data also underscore the metabolic consequences of some psychotropic agents.
我们旨在确定与普通人群相比,患有情绪障碍(即双相情感障碍或重度抑郁症)的个体中肥胖症的患病率。我们还旨在在控制社会人口统计学变量影响的同时,研究肥胖症与情绪障碍之间关联的可能性。
分析基于2002年加拿大统计局开展的加拿大社区健康调查:心理健康与幸福(CCHS 1.2)的数据。样本(n = 36984;年龄≥15岁)取自加拿大家庭居住人口。CCHS使用《精神疾病诊断与统计手册》第四版(DSM-IV)中概述的诊断标准对受访者进行筛查。
有情绪障碍终生病史的个体比没有情绪障碍终生病史的个体更有可能肥胖(体重指数[BMI]>30)(分别为19%和15%;P<0.001)。在按性别进行的多变量分析中,情绪障碍终生病史与女性受访者肥胖几率升高相关(95%CI,1.03至1.46,优势比1.22),但与男性受访者无关。抗精神病药物治疗也与肥胖相关。
这是加拿大首次专门评估情绪障碍患者人体测量指标及相关因素的流行病学调查。本文结果补充了大量临床证据,证明情绪障碍与应激敏感性躯体疾病(如肥胖症)之间存在关联。这些数据还强调了某些精神药物的代谢后果。